Innatoss Laboratories BV
Diagnostic laboratory focused on improved diagnostics for selected infectious diseases (notably Lyme disease, Q fever and SARS-CoV-2). Provides laboratory testing (serology and cellular assays), participates in international research consortia and offers CRO and occupational screening services. Operates research and diagnostic laboratories in the Netherlands and collaborates with clinical and academic partners.
Industries
Nr. of Employees
small (1-50)
Innatoss Laboratories BV
Patents
Products
T-cell based cellular test for Q-fever
A cellular (T‑cell) diagnostic test to detect prior or ongoing infection with Coxiella burnetii (Q-fever) used in research and clinical contexts.
Neutralizing antibody detection service for SARS-CoV-2
Public-facing laboratory service to detect functional neutralizing antibodies against SARS-CoV-2 using a surrogate neutralization assay.
Extended Lyme testing panel (multi-assay package)
An extended diagnostic package combining multiple serological assays for Lyme disease to improve detection coverage.
T-cell based cellular test for Q-fever
A cellular (T‑cell) diagnostic test to detect prior or ongoing infection with Coxiella burnetii (Q-fever) used in research and clinical contexts.
Neutralizing antibody detection service for SARS-CoV-2
Public-facing laboratory service to detect functional neutralizing antibodies against SARS-CoV-2 using a surrogate neutralization assay.
Extended Lyme testing panel (multi-assay package)
An extended diagnostic package combining multiple serological assays for Lyme disease to improve detection coverage.
Services
Clinical and research laboratory testing for infectious diseases using serological and cellular immune assays; services available to individuals, clinicians and institutions with mail-in sample options.
Annual screening programs for employee groups at elevated risk of tick exposure to detect infections early and reduce long-term sick leave.
Contract research services including T‑cell antigenicity screens, cytometry-based profiling and assay development within international research consortia.
Clinical and research laboratory testing for infectious diseases using serological and cellular immune assays; services available to individuals, clinicians and institutions with mail-in sample options.
Annual screening programs for employee groups at elevated risk of tick exposure to detect infections early and reduce long-term sick leave.
Contract research services including T‑cell antigenicity screens, cytometry-based profiling and assay development within international research consortia.
Expertise Areas
- Cellular immunodiagnostics
- Serological testing and neutralizing antibody assays
- Infectious disease diagnostics (Lyme, Q fever, SARS-CoV-2)
- Biomarker discovery for early diagnosis
Key Technologies
- ELISA
- Immunoblot / western blot
- ELISPOT
- Flow cytometry
News & Updates
Public laboratory service for detection of neutralizing antibodies against SARS-CoV-2 using a surrogate neutralization assay (service launched September 2020).
Partnership with a digital/clinical partner to develop clinical interpretation and reporting solutions for Lyme diagnostics under an EU-funded program.
Participation in a US-led consortium (Massachusetts General Hospital-led) for rapid Q-fever vaccine development.
Participation as the only Dutch laboratory in a EUROIMMUN proficiency test round for Lyme diagnostics, achieving all correct results on submitted assays.
Company nomination listed among innovative companies in the Netherlands (mentioned in investor information).
Public laboratory service for detection of neutralizing antibodies against SARS-CoV-2 using a surrogate neutralization assay (service launched September 2020).
Partnership with a digital/clinical partner to develop clinical interpretation and reporting solutions for Lyme diagnostics under an EU-funded program.
Participation in a US-led consortium (Massachusetts General Hospital-led) for rapid Q-fever vaccine development.
Participation as the only Dutch laboratory in a EUROIMMUN proficiency test round for Lyme diagnostics, achieving all correct results on submitted assays.
Company nomination listed among innovative companies in the Netherlands (mentioned in investor information).